GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » 6-1 Month Momentum %

Sphere Medical Holding (LSE:SPHR) 6-1 Month Momentum % : N/A% (As of Jun. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-06-12), Sphere Medical Holding's 6-1 Month Momentum % is N/A%.

The industry rank for Sphere Medical Holding's 6-1 Month Momentum % or its related term are showing as below:

LSE:SPHR's 6-1 Month Momentum % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -6.31
* Ranked among companies with meaningful 6-1 Month Momentum % only.

Competitive Comparison of Sphere Medical Holding's 6-1 Month Momentum %

For the Medical Devices subindustry, Sphere Medical Holding's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's 6-1 Month Momentum % falls into.



Sphere Medical Holding  (LSE:SPHR) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Sphere Medical Holding 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.